Close
Novotech
Jabsco PureFlo 21 Single Use

News

AI in Alzheimer Drug Development to Enhances Clinical Trials

Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to medical treatment. The study shows that AI can help design future clinical trials to be...

Nipah Virus Vaccines Enter Clinical Trials in Bangladesh

Two Vaccines against the Nipah virus, a deadly bat-borne virus, are scheduled to begin human clinical trials in Bangladesh, while intriguing medication candidates have demonstrated the ability to treat and prevent infection. While Nipah case numbers remain low, climate change...

LL-37: Immunity, Microbial Defense, and Regenerative Research

LL-37, a 37-amino acid peptide derived from the cathelicidin antimicrobial peptide precursor hCAP18, has emerged as a molecule of considerable research interest. Encoded by the CAMP gene, LL-37 is the only known cathelicidin and is expressed in a variety...

Sino BioPharm to Acquire LaNova Medicines for $950.9 M Deal

LaNova Medicines, which happens to be a cancer drugmaker that previously licensed medicines to AstraZeneca as well as Merck & Co., has gone on to agree to get acquired by Sino BioPharmaceuticals in a deal worth almost $951 million. In...

Rheumatoid Arthritis Treatment with Genetic Link Adds Hope

Researchers at the University of Edinburgh have gone on to identify a genetic link that could revolutionize rheumatoid arthritis treatment. This discovery now opens the doors to innovative drug development as well as better patient outcomes, potentially elevating the...

Sleep Lean Reviews – Is It Effective for Weight Loss?

Sleep Lean is a dietary supplement formulated for people who want to enhance deep sleep and support healthy weight loss. Designed as a dual-action formula, Sleep Lean helps user’s burn fat and rest well by targeting both stress levels...

CDSCO Moves to Online Submission for CGTP Trial Applications

As part of its continued efforts to streamline operations through digitisation, the Central Drugs Standard Control Organisation (CDSCO) has transitioned from offline to online acceptance of clinical trial applications for cell and gene therapies products (CGTP). The agency has also...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »